Drug profile · INN
emtricitabine + rilpivirine + tenofovir alafenamide
ODEFSEY
- Patents linked
- 0
- News articles
- 0
Quick answer
emtricitabine + rilpivirine + tenofovir alafenamide (ODEFSEY) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
Key facts
INN emtricitabine + rilpivirine + tenofovir alafenamide
Brand ODEFSEY
Originator Gilead Sciences Pty Limited
Frequently asked questions
What is emtricitabine + rilpivirine + tenofovir alafenamide?
emtricitabine + rilpivirine + tenofovir alafenamide (ODEFSEY) is an FDA-listed pharmaceutical active ingredient. Associated with Gilead Sciences Pty Limited.
What is the brand name for emtricitabine + rilpivirine + tenofovir alafenamide?
ODEFSEY is a marketed brand name for emtricitabine + rilpivirine + tenofovir alafenamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.